3 July 2023 National Requirements for the Local Person for Pharmacovigilance (LPPV) in the EU, UK and Switzerland
22 June 2023 Simplified reporting procedures for monitoring the safety of clinical trials: simplified procedures for sponsors
13 June 2023 Webinar – Requirements for a local contact person for pharmacovigilance: where do you need one?
20 April 2023 European Medicines Agency (EMA) strengthens PRIME (Priority Medicines) with new features
Training webinar on post-authorisation procedure management in IRIS for Marketing Authorisation Holders, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 November 2024, 10:00 (CET) to 12 November 2024, 11:30 (CET) By EMA – Events
Conversations on Cancer: Transforming patient lives by therapeutic and regulatory innovations, European Medicines Agency, Amsterdam, the Netherlands, from 1 February 2024, 15:30 (CET) to 1 February 2024, 17:00 (CET) By EMA – Events
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 October 2024 By EMA – News and press releases
Informative webinar on PMS Product User Interface usage and key actions for Marketing Authorisation Holders (with demo), Online, Amsterdam, the Netherlands, from 29 October 2024, 10:00 (CET) to 29 October 2024, 12:00 (CET) By EMA – Events
Submission of Manufacturers and Manufacturing Operations to Product Management Service (PMS), Online, European Medicines Agency, Amsterdam, the Netherlands, from 25 November 2024, 10:00 (CET) to 25 November 2024, 11:30 (CET) By EMA – Events